Search - tctmd.com

Displaying 41 - 60 of 1511

Sort: Relevancy | Date

Presentation TCT 2025

Five-Year Outcomes of Biodegradable-Polymer Versus Durable-Polymer Second-Generation Drug-Eluting Stents: A Collaborative Individual Patient Data Analysis of 40,214 Patients Enrolled in 22 Randomized Trials

Presenter: Daniele Giacoppo

October 25, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Industry News

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

September 15, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Daily News

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Yael L. Maxwell

January 15, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Presenter: Woo Jin Ahn

October 30, 2024

Presentation TCT 2024

Are Metallic Drug Eluting Stents As Good As it Gets?

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

Presenter: Joanna Wykrzykowska

October 30, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

Presenter: Seok Oh

October 29, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Presenter: Michael Joner

October 29, 2024

Advertisement

Five-Year Outcomes of Biodegradable-Polymer Versus Durable-Polymer Second-Generation Drug-Eluting Stents: A Collaborative Individual Patient Data Analysis of 40,214 Patients Enrolled in 22 Randomized Trials

What’s Going to Be Hot at TCT 2025

Positive 3-Year Results from FIRE Trial Demonstrate Supraflex Cruz’s Safety and Efficacy in Elderly Heart Attack Patients

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3

Top Coronary Artery Disease News in 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCT 261: Comparison of Clinical Outcomes Between First- and Second-Generation Drug-Eluting Stents in Single Vessel Disease Patients up to 10-Year Follow-up Results

Are Metallic Drug Eluting Stents As Good As it Gets?

Future Metallic Drug Eluting Stents: New Designs, Platforms, and Components

Lesion-Specific Drug Eluting Stents: Are They Still Needed?

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 502: Nicotine Inhibits Re-Endothelialization and Promotes Inflammation and Neoatherosclerosis After Drug-Eluting Stent Implantation in a Swine Model

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

TCT 422: Preclinical Assessment of a Novel Polymer-Free Hybrid Drug-Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content